February 25, 2025
V Foundation Translational Grant
The V Foundation is offering a 4-year grant of $800,000 grant ($200,000 per year) for translational research in the broad area of adult cancers, targeted towards those in their mid-to-senior-career.
Grant Description
These grants support “bench to bedside” research whose endpoint is often planning or initiation of a clinical trial. Translational projects should move a novel strategy from the laboratory to a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms.
UBC is invited to nominate 1 candidate, and is therefore holding an internal competition to determine its candidate. However, UBC is allowed to nominate a 2nd candidate in 2025 for an All-Star grant (they must have previously won and completed a V Foundation grant/award).
Key Dates
- UBC internal selection deadline: 28 Feb 2025 | 5pm
- Sponsor nomination deadline: 21 March 2025 (to be confirmed)
- Full application deadline: April 19, 2025 (to be confirmed)
Applications
Interested candidates should submit the following items by the 28 February internal deadline, to the contact listed on the UBC information page.
- UBC CV
- 3-page Draft Recommendation Letter (with department head confirmation of nomination)
- 1-page Research Proposal Summary
Quick Facts
- The grant allows for 10% indirect costs (not to exceed $80,000 within the award)
- Nominees must be the lead Principal Investigator (PI) on the Translational research team and must meet all of the following criteria by the nomination due date:
- Nominated by their Cancer Center Director or similar high ranking research official.
- Employed at a non-profit research institution
- Faculty must have dedicated lab space and committed research time
- Must be able to apply for PI status on major research grants
Does this interest you? If so, please visit the information page on UBC’s website, and on the V Foundation Website, for further information.
February 23, 2025
Lab2Market Validate Foundations
The Lab2Market program has announced a free 3-day virtual opportunity,Validate Foundations, aimed at physicians who contribute to health innovation. Clinician scientists who are researching emerging technologies may find this program relevant, as participants will be exposed to topics such as the process and best practices for research commercialization, initiation for commercialization endeavours, and strategic positioning to capitalize on various resource and support opportunities.
The Lab2Market website contains full details, background, and eligibility.
Validate Foundation Details
Cost
Free
3-Day Program
- Dates
- Monday 24 March
- Wednesday 26 March
- Friday 28 March 2025
- Times
- 11 am – 2 pm PT (each day)
Application Deadline
February 19, 2025
Call for Abstracts
Topics
The Canadian Society of Pharmacology and Therapeutics is a national not-for-profit charitable organization that aims to foster the application of educational and research excellence to drug discovery and therapeutic choice. Abstract submissions should fall within the scope of basic and/or clinical pharmacology.
Presentation Type
All abstracts will be submitted for Poster presentations. The Scientific Committee will determine if an abstract is accepted as: a(n) oral presentation, poster presentation, or journal publication. Accepted abstracts are published in the Canadian Journal of Physiology and Pharmacology and are posted online for registered meeting attendees.
Full details regarding abstracts are located here
Abstract Submissions
CSPT Travel Awards
Key Dates
- Abstract Submission Deadline (for travel award/oral presentation results eligibility): 17 March 2025
- Notification of travel award/oral presentation results: 10 April 2025
If you won’t be submitting an abstract but still want to learn more about the Annual Meeting, please visit here and here.
February 11, 2025
The Weston Family Foundation has announced the Rapid Response 2025 Program.
The Rapid Response Program provides seed funding to catalyze novel, high-risk, high-reward translational research that accelerates the development of therapeutics or tools for neurodegenerative diseases of aging (NDAs). The aim of the Weston Family Foundation is to catalyze and scale science-based approaches to significantly improve the health and well-being of Canadians.
Project Criteria
- Be translational research that can accelerate therapeutic or tool development for neurodegenerative diseases of aging, as defined by the Institute.
- Therapeutics should address unmet needs in the prevention, treatment and/or symptomatic management of NDAs.
- Tools should address challenges in translational research to accelerate the development and/or clinical implementation of therapeutics for NDAs (e.g., biomarkers, drug delivery systems). Projects covering only the discovery/identification of a tool are considered out of scope.
- Have preliminary data to support the hypothesis and feasibility of the project.
Funding
- Up to $300,000 over 18-24 months
Key Dates
- Letter of Intent Deadline: 18 March 2025 | 11am
- Award Announcement: November 2025
February 8, 2025
15-16 May 2025
In-person (The Nest, UBC Vancouver) and virtual
Free Event
Event Description
This event will connect partners from across BC’s health system to explore how research insights can be translated through dialogue into actionable strategies to improve health across the province. This event will bring together diverse perspectives and sectors to:
- Showcase Interdisciplinary Health Research and Innovations
- Learning from current research, innovations and impact will guide discussions about how to mobilize knowledge and implement approaches to develop transformative solutions across disciplines and sectors.
- Facilitate Connection and Dialogue
- Participants will engage in dynamic panels, interactive workshops, and working groups to tackle complex health challenges, co-create actionable strategies, and catalyze cross-campus and sector partnerships.
- Build Collaborations and Drive Change
- The event aims to foster collaborations between researchers, healthcare providers, policymakers, practitioners, and community members to establish shared goals and leave with actionable opportunities to integrate results from research into practice.
Intended Audience
- Healthcare providers
- health administrators
- Health researchers
- Policymakers
- Patient and community partners
- Other interest holders committed to bridging the knowledge-to-action gap in BC.
- UBC Health aims to ensure the engagement of diverse interest holders across the province with in-person sessions at both the UBC Vancouver and UBC Okanagan campuses, as well as opportunities to connect virtually.
Full Information can be found Here and Here
Call for Session Proposals
Applications are open for session proposals. Proposals should focus on collaborative solutions to pressing health challenges that support actionable outcomes. In particular, the following topics are requested.
- Research ready for implementation or collaborative engagement
- Health system challenges or innovations that require a research perspective
- Session formats include: implementation workshops, panel discussions, collaborative sessions, or innovative interactive formats.
January 29, 2025
2025 Clinical Trials Training Summit
Registration for in-person attendance to the 2025 Clinical Trials Training Summit has closed, however registration is still open for virtual attendance.
Click here to register!
Four Clinical Trials Training Programs unite to address key challenges in the clinical trials ecosystem.
Visit the website for full information
January 27, 2025
In Pathways, UBC Faculty of Medicine’s digital magazine, the feature story ‘Rethinking early-life brain injury’ is worth reading. The thorough article paints a comprehensive picture of the past perspectives on perinatal brain injuries, and how advancements in imaging and research initiatives are providing novel intel.
Dr. Thiviya Selvanathan and Dr. Steven Millar in the Pathways Feature Story ‘Rethinking early-life brain injury’.
Breakthrough research by Dr. Steven Miller (Head of the UBC Faculty of Medicine’s Department of Pediatrics) and colleagues has changed the traditional knowledge and approach to children who are at risk for and/or who acquire such injuries. This is giving clinicians and researchers more accurate information to identify those at risk, determine pain and health management strategies, as well as how the effects of early-life brain injuries on children’s lives as they age, and how their environment plays a role.
Making strides in such these complex interactions requires the synergistic efforts of leading experts. Luckily, there is no shortage of those locally. Amongst them is Dr. Thiviya Selvanathan, a Faculty Member of the Academy of Translational Medicine.
With one third of children born preterm experiencing such injuries, the team is drawing from evidence collected not just acutely in the hospital, “but the everyday experiences of these kids, from their earliest days in hospital to their day-to-day family life, have a profound effect on recovery,” says Dr. Thiviya Selvanathan.
The ATM looks forward to the impact that this knowledge will have, to benefit patient care. For details and the full story, visit here.
January 24, 2025
The 5 February 2025 deadline to apply for the CIHR Reviewer in Training Program is fast approaching!
Interested and eligible Early Career Researchers (ECRs) are encouraged to submit their applications ahead of the deadline. The CIHR Reviewer in Training (RiT) Program runs twice a year during the Spring and Fall Project Grant Competitions. It offers ECRs a learning opportunity to gain a better understanding of the elements of high-quality review and the peer review process.
Applicants can choose to apply as a Mentee or apply as an ECR Reviewer
- Mentees
- Mentees participate in the Project Grant competition with the support of a Mentor. They conduct practice reviews on up to three applications, attend the peer review meeting in full, present one review, and participate in the committee discussions.
- ECR Reviewers
- ECR Reviewers participate in the same capacity as regular reviewers and will have access to all of the supportive resources that CIHR provides to committee members. They will have a reduced number of applications to review (up to five) and be able to present their assigned applications later in the meeting.
Key Dates
- 5 February 2025: Application Deadline
- 19 March 2025: Results Deadline
- 13 May – 12 June 2025: Project Front Committee Members